Drug interactions and possible serotonin syndrome in a patient with fibromyalgia

Depression associated with fibromyalgia can be treated with selective serotonin reuptake inhibitors (SSRI) as fluoxetine, paroxetine or citalopram; or with serotonin–norepinephrine reuptake inhibitors (duloxetine or milnacipran). In patients with fibromyalgia, several meta-analyses have demonstrate...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Patricia de Carvalho MASTROIANNI, Fabiana Rossi VARALLO, Manuel MACHUCA
Formato:	article
Lenguaje:	EN
Publicado:	Universidad de Antioquia 2014
Materias:	bruxism serotonin syndrome medication therapy management pharmaceutical care Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675
Acceso en línea:	https://doaj.org/article/957d823b89434f538b61c7e8109ca983
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:957d823b89434f538b61c7e8109ca983
record_format	dspace
spelling	oai:doaj.org-article:957d823b89434f538b61c7e8109ca9832021-11-19T04:11:56ZDrug interactions and possible serotonin syndrome in a patient with fibromyalgia0121-40042145-2660https://doaj.org/article/957d823b89434f538b61c7e8109ca9832014-02-01T00:00:00Zhttps://revistas.udea.edu.co/index.php/vitae/article/view/18143https://doaj.org/toc/0121-4004https://doaj.org/toc/2145-2660 Depression associated with fibromyalgia can be treated with selective serotonin reuptake inhibitors (SSRI) as fluoxetine, paroxetine or citalopram; or with serotonin–norepinephrine reuptake inhibitors (duloxetine or milnacipran). In patients with fibromyalgia, several meta-analyses have demonstrated the effectiveness of antidepressants, particularly the tricyclic antidepressant (TCA) amitriptyline, which reduce the pain, fatigue, depression, and sleep disturbances. Additionally, tramadol, pregabalin, and gabapentin are other treatment options. Patricia de Carvalho MASTROIANNIFabiana Rossi VARALLOManuel MACHUCAUniversidad de Antioquiaarticlebruxismserotonin syndromemedication therapy managementpharmaceutical careFood processing and manufactureTP368-456Pharmaceutical industryHD9665-9675ENVitae, Vol 21, Iss 1 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	bruxism serotonin syndrome medication therapy management pharmaceutical care Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675
spellingShingle	bruxism serotonin syndrome medication therapy management pharmaceutical care Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675 Patricia de Carvalho MASTROIANNI Fabiana Rossi VARALLO Manuel MACHUCA Drug interactions and possible serotonin syndrome in a patient with fibromyalgia
description	Depression associated with fibromyalgia can be treated with selective serotonin reuptake inhibitors (SSRI) as fluoxetine, paroxetine or citalopram; or with serotonin–norepinephrine reuptake inhibitors (duloxetine or milnacipran). In patients with fibromyalgia, several meta-analyses have demonstrated the effectiveness of antidepressants, particularly the tricyclic antidepressant (TCA) amitriptyline, which reduce the pain, fatigue, depression, and sleep disturbances. Additionally, tramadol, pregabalin, and gabapentin are other treatment options.
format	article
author	Patricia de Carvalho MASTROIANNI Fabiana Rossi VARALLO Manuel MACHUCA
author_facet	Patricia de Carvalho MASTROIANNI Fabiana Rossi VARALLO Manuel MACHUCA
author_sort	Patricia de Carvalho MASTROIANNI
title	Drug interactions and possible serotonin syndrome in a patient with fibromyalgia
title_short	Drug interactions and possible serotonin syndrome in a patient with fibromyalgia
title_full	Drug interactions and possible serotonin syndrome in a patient with fibromyalgia
title_fullStr	Drug interactions and possible serotonin syndrome in a patient with fibromyalgia
title_full_unstemmed	Drug interactions and possible serotonin syndrome in a patient with fibromyalgia
title_sort	drug interactions and possible serotonin syndrome in a patient with fibromyalgia
publisher	Universidad de Antioquia
publishDate	2014
url	https://doaj.org/article/957d823b89434f538b61c7e8109ca983
work_keys_str_mv	AT patriciadecarvalhomastroianni druginteractionsandpossibleserotoninsyndromeinapatientwithfibromyalgia AT fabianarossivarallo druginteractionsandpossibleserotoninsyndromeinapatientwithfibromyalgia AT manuelmachuca druginteractionsandpossibleserotoninsyndromeinapatientwithfibromyalgia
_version_	1718420508371845120

Drug interactions and possible serotonin syndrome in a patient with fibromyalgia

Ejemplares similares